Post-market use of teduglutide (TED) in a large cohort of adults with short bowel syndrome (SBS)
Post-market use of teduglutide (TED) in a large cohort of adults with short bowel syndrome (SBS) is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Post-market use of teduglutide (TED) in a large cohort of adults with short bowel syndrome (SBS) have?
Post-market use of teduglutide (TED) in a large cohort of adults with short bowel syndrome (SBS) has 0 citations in the OpenAlex counts ScholarIQ stores.
When was Post-market use of teduglutide (TED) in a large cohort of adults with short bowel syndrome (SBS) published?
Post-market use of teduglutide (TED) in a large cohort of adults with short bowel syndrome (SBS) has 2023 year in the ScholarIQ index.
What is the open-access status of Post-market use of teduglutide (TED) in a large cohort of adults with short bowel syndrome (SBS)?
Post-market use of teduglutide (TED) in a large cohort of adults with short bowel syndrome (SBS) has bronze oa status in the ScholarIQ index.
What is the DOI of Post-market use of teduglutide (TED) in a large cohort of adults with short bowel syndrome (SBS)?
The DOI for Post-market use of teduglutide (TED) in a large cohort of adults with short bowel syndrome (SBS) is on the source record.
What is the OpenAlex record for Post-market use of teduglutide (TED) in a large cohort of adults with short bowel syndrome (SBS)?
The OpenAlex for Post-market use of teduglutide (TED) in a large cohort of adults with short bowel syndrome (SBS) is on the source record.